NFIC_HUMAN - dbPTM
NFIC_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NFIC_HUMAN
UniProt AC P08651
Protein Name Nuclear factor 1 C-type
Gene Name NFIC
Organism Homo sapiens (Human).
Sequence Length 508
Subcellular Localization Nucleus.
Protein Description Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication..
Protein Sequence MYSSPLCLTQDEFHPFIEALLPHVRAFAYTWFNLQARKRKYFKKHEKRMSKDEERAVKDELLGEKPEVKQKWASRLLAKLRKDIRPECREDFVLSITGKKAPGCVLSNPDQKGKMRRIDCLRQADKVWRLDLVMVILFKGIPLESTDGERLVKAAQCGHPVLCVQPHHIGVAVKELDLYLAYFVRERDAEQSGSPRTGMGSDQEDSKPITLDTTDFQESFVTSGVFSVTELIQVSRTPVVTGTGPNFSLGELQGHLAYDLNPASTGLRRTLPSTSSSGSKRHKSGSMEEDVDTSPGGDYYTSPSSPTSSSRNWTEDMEGGISSPVKKTEMDKSPFNSPSPQDSPRLSSFTQHHRPVIAVHSGIARSPHPSSALHFPTTSILPQTASTYFPHTAIRYPPHLNPQDPLKDLVSLACDPASQQPGPLNGSGQLKMPSHCLSAQMLAPPPPGLPRLALPPATKPATTSEGGATSPTSPSYSPPDTSPANRSFVGLGPRDPAGIYQAQSWYLG
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MYSSPLCL
-------CCCCCCCC
7.0820068231
2Phosphorylation------MYSSPLCLT
------CCCCCCCCC
20.1828450419
3Phosphorylation-----MYSSPLCLTQ
-----CCCCCCCCCC
24.9628450419
4Phosphorylation----MYSSPLCLTQD
----CCCCCCCCCCC
12.3825159151
9PhosphorylationYSSPLCLTQDEFHPF
CCCCCCCCCCHHHHH
32.7428450419
41PhosphorylationLQARKRKYFKKHEKR
HHHHHHHHHHHHHHH
25.3522817900
50PhosphorylationKKHEKRMSKDEERAV
HHHHHHCCHHHHHHH
40.7720068231
58AcetylationKDEERAVKDELLGEK
HHHHHHHHHHHCCCC
44.4926051181
58UbiquitinationKDEERAVKDELLGEK
HHHHHHHHHHHCCCC
44.49-
65AcetylationKDELLGEKPEVKQKW
HHHHCCCCHHHHHHH
44.6826051181
65UbiquitinationKDELLGEKPEVKQKW
HHHHCCCCHHHHHHH
44.68-
99UbiquitinationFVLSITGKKAPGCVL
CEEEEECCCCCCCCC
36.79-
112UbiquitinationVLSNPDQKGKMRRID
CCCCCCCCCCCCHHH
68.80-
146PhosphorylationKGIPLESTDGERLVK
CCCCCCCCCHHHHHH
38.35-
192PhosphorylationRERDAEQSGSPRTGM
HHHCHHHCCCCCCCC
32.5130266825
194PhosphorylationRDAEQSGSPRTGMGS
HCHHHCCCCCCCCCC
19.2230266825
194 (in isoform 5)Phosphorylation-19.2224719451
197PhosphorylationEQSGSPRTGMGSDQE
HHCCCCCCCCCCCCC
34.6024275569
201PhosphorylationSPRTGMGSDQEDSKP
CCCCCCCCCCCCCCC
27.5128102081
206PhosphorylationMGSDQEDSKPITLDT
CCCCCCCCCCEEEEC
39.3128102081
237PhosphorylationELIQVSRTPVVTGTG
HEEEEECCCEEECCC
16.9620068231
241PhosphorylationVSRTPVVTGTGPNFS
EECCCEEECCCCCCC
29.2920068231
243PhosphorylationRTPVVTGTGPNFSLG
CCCEEECCCCCCCHH
39.8523663014
248PhosphorylationTGTGPNFSLGELQGH
ECCCCCCCHHHHCCE
41.9523663014
258PhosphorylationELQGHLAYDLNPAST
HHCCEEEECCCHHCC
27.5923663014
264PhosphorylationAYDLNPASTGLRRTL
EECCCHHCCCHHHCC
25.0225159151
264 (in isoform 5)Phosphorylation-25.0224719451
265PhosphorylationYDLNPASTGLRRTLP
ECCCHHCCCHHHCCC
42.2028348404
270PhosphorylationASTGLRRTLPSTSSS
HCCCHHHCCCCCCCC
36.2628152594
273PhosphorylationGLRRTLPSTSSSGSK
CHHHCCCCCCCCCCC
43.9921955146
273 (in isoform 5)Phosphorylation-43.9924719451
274PhosphorylationLRRTLPSTSSSGSKR
HHHCCCCCCCCCCCC
30.5928152594
275O-linked_GlycosylationRRTLPSTSSSGSKRH
HHCCCCCCCCCCCCC
27.1830059200
275PhosphorylationRRTLPSTSSSGSKRH
HHCCCCCCCCCCCCC
27.1825159151
276PhosphorylationRTLPSTSSSGSKRHK
HCCCCCCCCCCCCCC
38.5123401153
277PhosphorylationTLPSTSSSGSKRHKS
CCCCCCCCCCCCCCC
47.0225159151
279PhosphorylationPSTSSSGSKRHKSGS
CCCCCCCCCCCCCCC
28.5925159151
280AcetylationSTSSSGSKRHKSGSM
CCCCCCCCCCCCCCC
63.1526051181
284PhosphorylationSGSKRHKSGSMEEDV
CCCCCCCCCCCCCCC
29.9423927012
284 (in isoform 5)Phosphorylation-29.9424719451
286PhosphorylationSKRHKSGSMEEDVDT
CCCCCCCCCCCCCCC
30.0623927012
286 (in isoform 5)Phosphorylation-30.0624719451
293PhosphorylationSMEEDVDTSPGGDYY
CCCCCCCCCCCCCCC
36.3530278072
293 (in isoform 5)Phosphorylation-36.3524719451
294PhosphorylationMEEDVDTSPGGDYYT
CCCCCCCCCCCCCCC
19.6523927012
294 (in isoform 5)Phosphorylation-19.6524719451
299PhosphorylationDTSPGGDYYTSPSSP
CCCCCCCCCCCCCCC
16.3630278072
300PhosphorylationTSPGGDYYTSPSSPT
CCCCCCCCCCCCCCC
12.8923927012
301PhosphorylationSPGGDYYTSPSSPTS
CCCCCCCCCCCCCCC
28.1223927012
302PhosphorylationPGGDYYTSPSSPTSS
CCCCCCCCCCCCCCC
13.4823927012
304PhosphorylationGDYYTSPSSPTSSSR
CCCCCCCCCCCCCCC
49.0323401153
304 (in isoform 5)Phosphorylation-49.0324719451
305PhosphorylationDYYTSPSSPTSSSRN
CCCCCCCCCCCCCCC
35.2623927012
307PhosphorylationYTSPSSPTSSSRNWT
CCCCCCCCCCCCCCC
43.0930278072
308PhosphorylationTSPSSPTSSSRNWTE
CCCCCCCCCCCCCCC
29.6930278072
309PhosphorylationSPSSPTSSSRNWTED
CCCCCCCCCCCCCCC
35.4830278072
310PhosphorylationPSSPTSSSRNWTEDM
CCCCCCCCCCCCCCC
29.4230278072
314PhosphorylationTSSSRNWTEDMEGGI
CCCCCCCCCCCCCCC
26.1722167270
322PhosphorylationEDMEGGISSPVKKTE
CCCCCCCCCCCCCCC
31.6822167270
323PhosphorylationDMEGGISSPVKKTEM
CCCCCCCCCCCCCCC
31.6222167270
323 (in isoform 5)Phosphorylation-31.6224719451
328PhosphorylationISSPVKKTEMDKSPF
CCCCCCCCCCCCCCC
30.7230266825
333PhosphorylationKKTEMDKSPFNSPSP
CCCCCCCCCCCCCCC
30.3829255136
337PhosphorylationMDKSPFNSPSPQDSP
CCCCCCCCCCCCCCC
27.4329255136
339PhosphorylationKSPFNSPSPQDSPRL
CCCCCCCCCCCCCCH
34.7129255136
339 (in isoform 5)Phosphorylation-34.7124719451
343PhosphorylationNSPSPQDSPRLSSFT
CCCCCCCCCCHHHHH
13.4829255136
343 (in isoform 5)Phosphorylation-13.4824719451
345MethylationPSPQDSPRLSSFTQH
CCCCCCCCHHHHHHC
51.67115384105
347PhosphorylationPQDSPRLSSFTQHHR
CCCCCCHHHHHHCCC
25.3727251275
348PhosphorylationQDSPRLSSFTQHHRP
CCCCCHHHHHHCCCC
36.5823401153
348 (in isoform 5)Phosphorylation-36.5824719451
350PhosphorylationSPRLSSFTQHHRPVI
CCCHHHHHHCCCCEE
29.0128348404
361PhosphorylationRPVIAVHSGIARSPH
CCEEEEECCCCCCCC
25.8723312004
365Asymmetric dimethylarginineAVHSGIARSPHPSSA
EEECCCCCCCCCCCC
49.12-
365MethylationAVHSGIARSPHPSSA
EEECCCCCCCCCCCC
49.1224129315
366PhosphorylationVHSGIARSPHPSSAL
EECCCCCCCCCCCCC
20.6625159151
370PhosphorylationIARSPHPSSALHFPT
CCCCCCCCCCCCCCC
25.8028152594
371PhosphorylationARSPHPSSALHFPTT
CCCCCCCCCCCCCCC
39.0228152594
377PhosphorylationSSALHFPTTSILPQT
CCCCCCCCCCCCCCC
32.0328450419
378PhosphorylationSALHFPTTSILPQTA
CCCCCCCCCCCCCCC
17.6328450419
379PhosphorylationALHFPTTSILPQTAS
CCCCCCCCCCCCCCC
25.3028450419
395Asymmetric dimethylarginineYFPHTAIRYPPHLNP
CCCCCCCCCCCCCCC
35.13-
395MethylationYFPHTAIRYPPHLNP
CCCCCCCCCCCCCCC
35.1324129315
396PhosphorylationFPHTAIRYPPHLNPQ
CCCCCCCCCCCCCCC
18.2729632367
427PhosphorylationQPGPLNGSGQLKMPS
CCCCCCCCCCCCCCH
23.4620886841
434PhosphorylationSGQLKMPSHCLSAQM
CCCCCCCHHHEEHHH
24.2723186163
438PhosphorylationKMPSHCLSAQMLAPP
CCCHHHEEHHHCCCC
23.1123917254
451MethylationPPPPGLPRLALPPAT
CCCCCCCCCCCCCCC
37.3224129315
458PhosphorylationRLALPPATKPATTSE
CCCCCCCCCCCCCCC
43.2523186163
459AcetylationLALPPATKPATTSEG
CCCCCCCCCCCCCCC
34.4626051181
460 (in isoform 2)Phosphorylation-30.4024719451
462PhosphorylationPPATKPATTSEGGAT
CCCCCCCCCCCCCCC
39.1125850435
463PhosphorylationPATKPATTSEGGATS
CCCCCCCCCCCCCCC
27.2125850435
463 (in isoform 2)Phosphorylation-27.2124719451
464PhosphorylationATKPATTSEGGATSP
CCCCCCCCCCCCCCC
29.8625850435
464 (in isoform 2)Phosphorylation-29.8624719451
469PhosphorylationTTSEGGATSPTSPSY
CCCCCCCCCCCCCCC
38.2126657352
470PhosphorylationTSEGGATSPTSPSYS
CCCCCCCCCCCCCCC
26.1630576142
472PhosphorylationEGGATSPTSPSYSPP
CCCCCCCCCCCCCCC
53.7025159151
473PhosphorylationGGATSPTSPSYSPPD
CCCCCCCCCCCCCCC
18.4225159151
475PhosphorylationATSPTSPSYSPPDTS
CCCCCCCCCCCCCCC
37.7025850435
476PhosphorylationTSPTSPSYSPPDTSP
CCCCCCCCCCCCCCC
28.6929116813
477PhosphorylationSPTSPSYSPPDTSPA
CCCCCCCCCCCCCCC
34.0025850435
481PhosphorylationPSYSPPDTSPANRSF
CCCCCCCCCCCCCCC
42.2424275569
482PhosphorylationSYSPPDTSPANRSFV
CCCCCCCCCCCCCCC
29.4227732954
487PhosphorylationDTSPANRSFVGLGPR
CCCCCCCCCCCCCCC
24.888710515

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of NFIC_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NFIC_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NFIC_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
LLPH_HUMANLLPHphysical
16189514
TPD55_HUMANTPD52L3physical
16189514
ZCH14_HUMANZCCHC14physical
16189514
ZKSC7_HUMANZKSCAN7physical
16189514
TKTL2_HUMANTKTL2physical
16189514
SMAD3_HUMANSMAD3physical
22195013
SMUF1_HUMANSMURF1physical
22195013

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NFIC_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-333, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-294; SER-305; SER-323;SER-333 AND SER-339, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304; SER-305; SER-339AND SER-343, AND MASS SPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323 AND SER-339, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-194; SER-323;SER-333 AND SER-339, AND MASS SPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194; SER-333 ANDSER-339, AND MASS SPECTROMETRY.

TOP